Anuh Pharma Receives GMP Certificate for  Anti-Bacterial Drug Blows Up 2.4%

Anuh Pharma is one of the leading manufacturers of Active Pharmaceutical Ingredients (API's). Registered in 1960, the company has grown several folds and earned recognition besides gaining the trust of a strong customer base.

The Anuh pharma has announced that it has received Good Manufacturing Practice Certificate from COFEPRIS (Health Authority of Mexico) for its anti-bacterial drugs, Chloramphenicol and Chloramphenicol Palmitate.

“The company also expects approval for other product in coming 15 days but cannot reveal the details yet”, said Bipin Shah, MD, Anuh Pharma.

Anuh Pharma Ltd surged 2.4% to Rs. 311.10 on Bombay Stock Exchange (BSE). The pharma company has announced that it has received Good Manufacturing Practice (GMP) Certificate from COFEPRIS (Health Authority of Mexico) for its anti-bacterial drugs, Chloramphenicol and Chloramphenicol Palmitate. Chloramphenicol is an antibiotic useful for the treatment of a number of bacterial infections. This includes meningitis, plague, cholera, and typhoid fever.